CNCR Holdings

The Cancer Immunotherapy ETF

ETF Information as of 11/15/2018

ETF Holdings

COMPANY NAME ↓ TICKER ↓ CUSIP ↓ SHARES ↓ MARKET VALUE ↓ % OF NET ASSETS ↓
MERCK & CO INC MRK 58933Y105 37,561 $2,811,065.24 6.16%
ASTRAZENECA PLC AZN 046353108 63,856 $2,643,638.40 5.79%
NOVARTIS A G NVS 66987V109 30,239 $2,638,050.36 5.78%
FATE THERAPEUTICS INC FATE 31189P102 190,374 $2,396,808.66 5.25%
BRISTOL MYERS SQUIBB CO BMY 110122108 43,409 $2,312,397.43 5.07%
GILEAD SCIENCES INC GILD 375558103 32,519 $2,269,175.82 4.97%
MORPHOSYS AG MOR 617760202 79,878 $2,223,803.52 4.87%
XENCOR INC XNCR 98401F105 56,162 $2,188,071.52 4.79%
ATARA BIOTHERAPEUTICS INC ATRA 046513107 50,356 $1,805,262.60 3.95%
MIRATI THERAPEUTICS INC MRTX 60468T105 46,524 $1,805,131.20 3.95%
ZYMEWORKS INC ZYME 98985W102 139,144 $1,793,566.16 3.93%
MACROGENICS INC MGNX 556099109 102,164 $1,785,826.72 3.91%
DYNAVAX TECHNOLOGIES CORP DVAX 268158201 144,129 $1,733,871.87 3.80%
IOVANCE BIOTHERAPEUTICS INC IOVA 462260100 175,491 $1,674,184.14 3.67%
BEIGENE LTD BGNE 07725L102 13,141 $1,668,907.00 3.66%
CELLECTIS S A CLLS 15117K103 73,818 $1,661,643.18 3.64%
ARCUS BIOSCIENCES INC RCUS 03969F109 143,131 $1,658,888.29 3.63%
ZIOPHARM ONCOLOGY INC ZIOP 98973P101 538,325 $1,658,041.00 3.63%
NEKTAR THERAPEUTICS NKTR 640268108 40,750 $1,556,242.50 3.41%
FIVE PRIME THERAPEUTICS INC FPRX 33830X104 130,310 $1,507,686.70 3.30%
BLUEBIRD BIO INC BLUE 09609G100 11,670 $1,432,842.60 3.14%
CYTOMX THERAPEUTICS INC CTMX 23284F105 91,581 $1,294,955.34 2.84%
SORRENTO THERAPEUTICS INC SRNE 83587F202 312,148 $1,123,732.80 2.46%
ADAPTIMMUNE THERAPEUTICS PLC SPONDS ADR ADAP 00653A107 187,588 $1,031,734.00 2.26%
ADURO BIOTECH INC ADRO 00739L101 298,527 $982,153.83 2.15%
Cash & Other Cash&Other Cash&Other -10,540.88 $-10,540.88 -0.02%
*ETF holdings and allocations are subject to change at any time and should not be interpreted as an offer of these securities